Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Eur J Orthop Surg Traumatol ; 33(4): 1037-1041, 2023 May.
Artigo em Inglês | MEDLINE | ID: mdl-35377072

RESUMO

BACKGROUND: Aim is to identify if age, sex, type of posterolateral approach (mini vs standard), surgical time and time from surgery to drainage removal were independent risk factors for heterotopic ossifications after total hip arthroplasty. MATERIALS AND METHODS: Patients who underwent a THA with posterolateral approach during a 15 years period were included. The exclusion criteria were absence of X-rays follow-up or HO prophylaxis protocol adoption. The following data were collected: age, sex, type of approach (classical/minimal-invasive), surgical time, time from surgery to drainage removal. Two orthopedic surgeons independently reviewed the 2 years follow-up X-rays and classified the HO according to Brooker classification. Severe HO was defined if HO were classified as major than grade 2. Correlation between severe HO and risk factor has been tested with multivariable analysis. RESULTS: About 1225 patients were included: mean age of 63.8 years, 504 were men. HO were found in 67.6%. Men showed higher severe HO rate than woman (44.1% vs 29.1%, p = 0.001). Patients older than 65 years showed higher severe HO rate (30.3% vs 39.9%, p = 0.002). Standard posterolateral approach was performed in 75.4% and severe HO rate was 32.8% versus 27.1% in those treated with the minimally invasive approach (p = 0.067). In 75.6% of cases surgery lasted less than 90 min and this group showed a severe HO rate in 29.1%, while patient with longer surgical time showed a rate of 35.7% (p = 0.033). In 47.4% of patients, the drainage was removed in the first post-operative day, in this group severe HO rate was significantly lower than the others: 24.8 versus 36.2% (p = 0.001). DISCUSSION: Male sex, age older than 65 years, surgical time longer than 90 min and delayed drainage removal are risk factors for severe HO. Patients with one or more of those risk factors should be identified as good candidates for HO prophylaxis.


Assuntos
Artroplastia de Quadril , Ossificação Heterotópica , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Idoso , Artroplastia de Quadril/efeitos adversos , Fatores de Risco , Ossificação Heterotópica/etiologia , Drenagem/efeitos adversos , Radiografia
2.
Aquat Toxicol ; 59(3-4): 283-96, 2002 Sep 24.
Artigo em Inglês | MEDLINE | ID: mdl-12127742

RESUMO

The aim of this study was to evaluate the influence of the two-step hepatocyte isolation procedure on primary cultured trout (Oncorhynchus mykiss) hepatocytes over time. We characterised the possible changes of a variety of some cellular parameters within the first 24-48 h after seeding. We followed the time dependent changes of these parameters during subsequent culture times in order to see if the cells maintained a differentiated status. Scanning electron microscopy revealed bleb formation and 20% cell damage in freshly isolated hepatocytes. During subsequent culture times the bleb dimension appear to be reduced. Heat shock proteins 70 and 50 (HSP70, HSP50) were induced by hepatocyte isolation. During the first 4 h of culture, the hepatocytes showed a variation in mitochondrial activity, an increase in free radical species (ROS), and a decrease in both glutathione (GSH) content and catalase (CAT) activity; the generation of free radicals led to an increase in the formation of 8-hydroxydeoxyguanosine (8-OHdG) in the DNA. The cells showed detectable ethoxyresorufin-O-deethylase activity after 4 h of culture, which had rapidly increased by the 24th hour. After 24 h, mitochondrial and CAT activity, free radical production, and the content of GSH and 8-OHdG returned to their original levels. P450 activity was retained for at least 48 h after seeding. Our data show that trout hepatocytes suffer significant cell injury as a result of the isolation procedure, but primary cultured cells metabolically recover from this stress after a few hours: they are capable of repairing their damaged surfaces, recovering their antioxidant defences and retaining their ability to repair DNA. Our results also confirm that trout hepatocytes in a primary culture maintain their in vivo-like metabolic activities for 3-8 days.


Assuntos
Citocromo P-450 CYP1A1/metabolismo , Guanina/análogos & derivados , Proteínas de Choque Térmico/metabolismo , Hepatócitos/citologia , Hepatócitos/enzimologia , Oncorhynchus mykiss , 8-Hidroxi-2'-Desoxiguanosina/análogos & derivados , Animais , Catalase/metabolismo , Técnicas de Cultura de Células/métodos , Diferenciação Celular/fisiologia , Células Cultivadas , Reparo do DNA , Glutationa/biossíntese , Guanina/biossíntese , Proteínas de Choque Térmico HSP70 , Hepatócitos/ultraestrutura , Microscopia Eletrônica de Varredura , Oxirredução , Espécies Reativas de Oxigênio , Fatores de Tempo
3.
Altern Lab Anim ; 30(1): 77-85, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-11827572

RESUMO

In order to develop a method for detecting metabolism-mediated embryotoxicity, differentiating embryonic stem (ES) cells were exposed to the well-known proteratogen, cyclophosphamide (CPA). CPA was tested in a scientifically validated embryonic stem-cell test (EST), and in the newly developed reporter-gene assay for developmental cardiotoxicity. Both assays gave false-negative results. Because no metabolic competence (cytochrome P450 [CYP] activity) was found in the ES cells under the selected culture conditions, a simple biotransformation system was combined with the reporter-gene assay. As the metabolic pathway of CPA is well characterised, the genetically engineered mammalian cell line V79, transfected with CYP2B1 cDNA, was selected as a biotransformation system. CYP2B1 is responsible for transforming CPA into teratogenically active metabolites. The supernatants of genetically engineered V79 cells were analysed in the reporter-gene assay for developmental cardiotoxicity. In preliminary experiments, the combined system was able to detect the embryotoxic potential of the proteratogen, CPA.


Assuntos
Ciclofosfamida/toxicidade , Embrião de Mamíferos , Células-Tronco/efeitos dos fármacos , Testes de Toxicidade , Animais , Linhagem Celular , Cricetinae , Cricetulus , Citocromo P-450 CYP2B1/genética , Citocromo P-450 CYP2B1/metabolismo , Sistema Enzimático do Citocromo P-450/metabolismo , Reações Falso-Negativas , Expressão Gênica/efeitos dos fármacos , Proteínas de Fluorescência Verde , Isoenzimas/metabolismo , Proteínas Luminescentes/genética , Pulmão , Microssomos Hepáticos , Oxazinas/metabolismo , Ratos , Transfecção
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA